Cross Country Healthcare Inc
NASDAQ:CCRN

Watchlist Manager
Cross Country Healthcare Inc Logo
Cross Country Healthcare Inc
NASDAQ:CCRN
Watchlist
Price: 18 USD Market Closed
Market Cap: 592.6m USD
Have any thoughts about
Cross Country Healthcare Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one CCRN stock under the Base Case scenario is 21.8 USD. Compared to the current market price of 18 USD, Cross Country Healthcare Inc is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CCRN Relative Value
Base Case
21.8 USD
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
33
vs Industry
85
Median 3Y
0.4
Median 5Y
0.4
Industry
2.3
Forward
0.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
38
Median 3Y
6.1
Median 5Y
5.1
Industry
23.2
Forward
32.7
More Details
5.4
P/OCF
P/OCF
Price to OCF
5.4
vs History
36
vs Industry
51
Median 3Y
3
Median 5Y
3.3
Industry
14.3
More Details
5.9
P/FCFE
P/FCFE
Price to FCFE
5.9
vs History
57
vs Industry
34
Median 3Y
9.1
Median 5Y
7.6
Industry
20.1
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
80
vs Industry
60
Median 3Y
1.9
Median 5Y
2
Industry
2.2
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
65
vs Industry
85
Median 3Y
0.4
Median 5Y
0.4
Industry
2.4
Forward
0.4
More Details
1.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.7
vs History
55
vs Industry
76
Median 3Y
1.7
Median 5Y
1.8
Industry
5
More Details
16.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.6
vs History
9
vs Industry
45
Median 3Y
4.7
Median 5Y
8.8
Industry
12.8
Forward
9.9
More Details
39.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.5
vs History
14
vs Industry
43
Median 3Y
5.3
Median 5Y
11.8
Industry
17.2
Forward
43.1
More Details
4.8
EV/OCF
EV/OCF
Enterprise Value to OCF
4.8
vs History
38
vs Industry
51
Median 3Y
2.9
Median 5Y
3.1
Industry
14
More Details
5.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5.3
vs History
36
vs Industry
41
Median 3Y
3.1
Median 5Y
3.3
Industry
18.2
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
69
vs Industry
62
Median 3Y
1.4
Median 5Y
1.3
Industry
1.9
More Details

Multiples Across Competitors

CCRN Competitors Multiples
Cross Country Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cross Country Healthcare Inc
NASDAQ:CCRN
586m USD 0.4 -332.2 16.6 39.5
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1
P/E Multiple
Earnings Growth PEG
US
Cross Country Healthcare Inc
NASDAQ:CCRN
Average P/E: 27
Negative Multiple: -332.2
-32%
N/A
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
Cigna Corp
NYSE:CI
25.6
25%
1
US
CVS Health Corp
NYSE:CVS
11.2
3%
3.7
DE
Fresenius Medical Care AG
XMUN:FME
49
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.3
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.4
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.5
31%
0.8
US
DaVita Inc
NYSE:DVA
15.4
17%
0.9

See Also

Summary
CCRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCRN stock valuation using valuation multiples.
Wall Street Estimates
CCRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.